2-chloro-4-(cyclohexen-1-yl)-6-methoxy-7-(3-pyrrolidin-1-ylpropoxy)quinazoline;2-chloro-4-cyclohexyl-6-methoxy-7-(3-pyrrolidin-1-ylpropoxy)quinazoline;cyclohexen-1-ylboronic acid;4-cyclohexyl-6-methoxy-N-methyl-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-2-amine;2,4-dichloro-6-methoxy-7-(3-pyrrolidin-1-ylpropoxy)quinazoline;methanamine
C90H127BCl4N14O10 — CID 158841668
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-chloro-4-(cyclohexen-1-yl)-6-methoxy-7-(3-pyrrolidin-1-ylpropoxy)quinazoline;2-chloro-4-cyclohexyl-6-methoxy-7-(3-pyrrolidin-1-ylpropoxy)quinazoline;cyclohexen-1-ylboronic acid;4-cyclohexyl-6-methoxy-N-methyl-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-2-amine;2,4-dichloro-6-methoxy-7-(3-pyrrolidin-1-ylpropoxy)quinazoline;methanamine
2-chloro-4-(cyclohexen-1-yl)-6-methoxy-7-(3-pyrrolidin-1-ylpropoxy)quinazoline;2-chloro-4-cyclohexyl-6-methoxy-7-(3-pyrrolidin-1-ylpropoxy)quinazoline;cyclohexen-1-ylboronic acid;4-cyclohexyl-6-methoxy-N-methyl-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-2-amine;2,4-dichloro-6-methoxy-7-(3-pyrrolidin-1-ylpropoxy)quinazoline;methanamine (PubChem CID 158841668) has the molecular formula C90H127BCl4N14O10 and a molecular weight of 1717.72 g/mol. Its IUPAC name is 2-chloro-4-(cyclohexen-1-yl)-6-methoxy-7-(3-pyrrolidin-1-ylpropoxy)quinazoline;2-chloro-4-cyclohexyl-6-methoxy-7-(3-pyrrolidin-1-ylpropoxy)quinazoline;cyclohexen-1-ylboronic acid;4-cyclohexyl-6-methoxy-N-methyl-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-2-amine;2,4-dichloro-6-methoxy-7-(3-pyrrolidin-1-ylpropoxy)quinazoline;methanamine.
Molecular Properties
| Compound Name | 2-chloro-4-(cyclohexen-1-yl)-6-methoxy-7-(3-pyrrolidin-1-ylpropoxy)quinazoline;2-chloro-4-cyclohexyl-6-methoxy-7-(3-pyrrolidin-1-ylpropoxy)quinazoline;cyclohexen-1-ylboronic acid;4-cyclohexyl-6-methoxy-N-methyl-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-2-amine;2,4-dichloro-6-methoxy-7-(3-pyrrolidin-1-ylpropoxy)quinazoline;methanamine |
|---|---|
| PubChem CID | 158841668 |
| Molecular Formula | C90H127BCl4N14O10 |
| Molecular Weight | 1717.72 g/mol |
| Exact Mass | 1714.87 |
| IUPAC Name | 2-chloro-4-(cyclohexen-1-yl)-6-methoxy-7-(3-pyrrolidin-1-ylpropoxy)quinazoline;2-chloro-4-cyclohexyl-6-methoxy-7-(3-pyrrolidin-1-ylpropoxy)quinazoline;cyclohexen-1-ylboronic acid;4-cyclohexyl-6-methoxy-N-methyl-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-2-amine;2,4-dichloro-6-methoxy-7-(3-pyrrolidin-1-ylpropoxy)quinazoline;methanamine |
| SMILES | CN.CNc1nc(C2CCCCC2)c2cc(OC)c(OCCCN3CCCC3)cc2n1.COc1cc2c(C3=CCCCC3)nc(Cl)nc2cc1OCCCN1CCCC1.COc1cc2c(C3CCCCC3)nc(Cl)nc2cc1OCCCN1CCCC1.COc1cc2c(Cl)nc(Cl)nc2cc1OCCCN1CCCC1.OB(O)C1=CCCCC1 |
| InChI | InChI=1S/C23H34N4O2.C22H30ClN3O2.C22H28ClN3O2.C16H19Cl2N3O2.C6H11BO2.CH5N/c1-24-23-25-19-16-21(29-14-8-13-27-11-6-7-12-27)20(28-2)15-18(19)22(26-23)17-9-4-3-5-10-17;2*1-27-19-14-17-18(15-20(19)28-13-7-12-26-10-5-6-11-26)24-22(23)25-21(17)16-8-3-2-4-9-16;1-22-13-9-11-12(19-16(18)20-15(11)17)10-14(13)23-8-4-7-21-5-2-3-6-21;8-7(9)6-4-2-1-3-5-6;1-2/h15-17H,3-14H2,1-2H3,(H,24,25,26);14-16H,2-13H2,1H3;8,14-15H,2-7,9-13H2,1H3;9-10H,2-8H2,1H3;4,8-9H,1-3,5H2;2H2,1H3 |
| InChIKey | IYHZOGHQBQIRKG-UHFFFAOYSA-N |
| XLogP | 18.79 |
| TPSA | 268.43 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 24 |
| Rotatable Bonds | 29 |
| Heavy Atoms | 119 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1717.72 |
| LogP ≤ 5 | 18.79 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 24 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158841668 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.